Browse studies

Find your next paid study

27,332 recruiting studies available now

Comparison of Immune Response Following Posterior Spinal Fusion in Patients With Idiopathic vs. Neuromuscular Scoliosis

The objective of this study is to evaluate the immune response to posterior spinal fusion (PSF) in patients with neuromuscular scoliosis, comparing patients wi…

Posterior Spinal FusionIdiopathic ScoliosisNeuromuscular Scoliosis

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Ambrish PatelNCT07734467

Phase 1

A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease

This study is being conducted to understand changes in brain activity following administration of two different drugs (Psilocybin and Dextromethorphan) in olde…

Anhedonia in Healthy VolunteersOlder Adults (50-90 Years)

Estimated

~$500 – $11,250

Actual pay is set by the research site.

Jennifer MitchellNCT07386730

Phase 4

Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-Risk Patients With the Use of the Dye-Vert Plus System

Coronary angiography (CAG) for diagnostic or therapeutic purposes such as percutaneous coronary intervention (PCI) is one of the common procedures which requir…

AKI (Acute Kidney Injury) Due to Trauma

Estimated

~$25 – $1,000

Actual pay is set by the research site.

CAMC Health SystemNCT04279457

Observational

Pilot Testing of the Worldwide Yearly Screening for Hypospadias

The purpose of this study is to recruit approximately 20 male participants who have a history of repaired hypospadias to test the feasibility and acceptability…

Hypospadias

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Wisconsin, MadisonNCT06966375

Phase 1

An Open-Label, Multicenter, Phase 1a/1b, Dose Escalation/Dose Expansion Clinical Trial of Theranostic Pair PD-32766D, a 64Cu-Labeled Peptide and PD-32766T, an 225Ac-Labeled Peptide Targeting Carbonic Anhydrase IX in Adult Participants With Relapsed or Refractory Clear Cell Renal Cell Carcinoma Who Have Progressed From or Could Not be Administered Due to Medical Unsuitability or Limited Access to All Standard of Care Therapies

This is an open-label, multicenter, Phase 1a/1b study evaluating the theranostic pair 64Cu-PD-32766 Injection (PD-32766D) and 225Ac-PD-32766 Injection (PD-3276…

Clear Cell Renal Cell Carcinoma

Estimated

~$150 – $4,200

Actual pay is set by the research site.

PeptiDream Inc.NCT07688187

Observational

Examining the Effectiveness of a Data Coaching Process to Increase Child Physical Activity, Perceived Motor Competence, and Staff Physical Activity Promoting Practices: A Randomized Controlled Trial

The goal of this study is to determine whether a data coaching process called Out of School Time Coach (OST-Coach) can increase child physical activity (PA) be…

Physical Activity

Estimated

~$10 – $750

Actual pay is set by the research site.

Kansas State UniversityNCT07195409

Phase 2

Rifaximin Versus No Intervention in Patients With IgG/IgA (Non-IgM) Monoclonal Gammopathy of Undetermined Significance

This phase II trial compares the effect of rifaximin to no intervention for the treatment of IgG/IgA monoclonal gammopathy of undetermined significance (MGUS).…

IgA Monoclonal Gammopathy of Undetermined SignificanceNon-IgM Monoclonal Gammopathy of Undetermined Significance

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Fred Hutchinson Cancer CenterNCT07209371

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania

The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.

Breast Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT05438511

Phase 3

Multicenter, Prospective, Double-Blinded, Parallel Group, Randomized Phase III Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

Pediatric Chronic Inflammatory Demyelinating Polyneuropathy

Estimated

~$50 – $2,100

Actual pay is set by the research site.

OctapharmaNCT04929236

Observational

Identification of Biomarkers for Stress Vulnerability and Resilience

The purpose of this research study is to understand the biological mechanisms of stress vulnerability (being susceptible to stress) and stress resilience (bein…

Healthy

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MichiganNCT05498207

Phase 4

A Randomized Double Blind Trial of Vasoactive Drugs for the Management of Shock in the ICU

The investigators hypothesis is that for ICU patients with shock, the use of the vasoactive drugs phenylephrine and vasopressin will reduce tachydysrhythmias w…

Shock

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of ChicagoNCT02118467

Phase 1

A Phase 1/2, Open-Label, Dose-Escalation and Expansion First-In-Human Study of ATX-295, an Oral Inhibitor of the Kinesin Motor Protein KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Locally Advanced or Metastatic Solid Tumors, Including High-Grade Serous Ovarian Cancer

The goal of this study is to identify a safe and tolerated dose of the orally administered KIF18A inhibitor ATX-295. In addition, this study will evaluate the …

Advanced Solid TumorsBreast Cancer RecurrentOvarian Cancer+4 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Accent TherapeuticsNCT06799065